bucladesine has been researched along with Di Guglielmo Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mills, JC; Nachmias, VT; Niu, MY | 1 |
| Brodbeck, KC; Castronuevo, P; Petrushina, I; Schick, BP | 1 |
| Brooks, E; Choi, P; Flickinger, RA; Morlock, M; Parker, B; Snider, J | 1 |
| Amici, C; Benedetto, A; Crisari, A; Santoro, MG | 1 |
| Lacal, JC; Lapetina, EG; Lazarowski, ER | 1 |
| Mason, M; Narindrasorasak, S; Sanwal, BD | 1 |
| Brahmi, Z; Steele, TA | 1 |
| Kufe, DW; Shafman, TD; Sherman, ML | 1 |
8 other study(ies) available for bucladesine and Di Guglielmo Disease
| Article | Year |
|---|---|
Development of polarity in human erythroleukemia cells: roles of membrane ruffling and the centrosome.
Topics: Bucladesine; Cell Membrane; Cell Polarity; Cell Size; Centrosome; Humans; Leukemia, Erythroblastic, Acute; Microtubules; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1997 |
Promoter regulatory elements and DNase I-hypersensitive sites involved in serglycin proteoglycan gene expression in human erythroleukemia, CHRF 288-11, and HL-60 cells.
Topics: Bucladesine; Deoxyribonuclease I; Gene Expression Regulation, Neoplastic; Helix-Loop-Helix Motifs; HL-60 Cells; Humans; Introns; Leukemia, Erythroblastic, Acute; Megakaryocytes; Promoter Regions, Genetic; Proteoglycans; RNA, Messenger; Tetradecanoylphorbol Acetate; Vesicular Transport Proteins | 2001 |
Possible role of H1 histone in the differentiation of mouse erythroleukemia cells.
Topics: Animals; Blood; Bucladesine; Cell Differentiation; Culture Media; Cycloheximide; Histones; Leukemia, Erythroblastic, Acute; Mice; Tumor Cells, Cultured | 1990 |
Modulation of the growth of a human erythroleukemic cell line (K562) by prostaglandins: antiproliferative action of prostaglandin A.
Topics: Bucladesine; Cell Division; Cell Line; DNA; Humans; Leukemia, Erythroblastic, Acute; Prostaglandins; Prostaglandins A; Protein Biosynthesis; RNA | 1986 |
Agonist-induced phosphorylation of an immunologically ras-related protein in human erythroleukemia cells.
Topics: Antibodies, Monoclonal; Bucladesine; Cell Line; Cell Membrane; Cytosol; Epitopes; Epoprostenol; Humans; Iloprost; Leukemia, Erythroblastic, Acute; Membrane Proteins; Molecular Weight; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Theophylline; Tumor Cells, Cultured | 1989 |
Regulation of cyclic 3',5'-adenosine monophosphate phosphodiesterase in Friend erythroleukemia cells.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Bucladesine; Cells, Cultured; Chromatography, DEAE-Cellulose; Enzyme Activation; Friend murine leukemia virus; Leukemia, Erythroblastic, Acute; Radioimmunoassay | 1985 |
Phosphatidylinositol metabolism accompanies early activation events in tumor target cell-stimulated human natural killer cells.
Topics: Adult; Bucladesine; Calcium; Cell Line; Cytotoxicity, Immunologic; Extracellular Space; Humans; Killer Cells, Natural; Kinetics; Leukemia, Erythroblastic, Acute; Lymphocyte Activation; Phosphatidylinositols; Quercetin; Theophylline | 1988 |
Inhibitory effects of theophylline and dibutyryl cAMP on murine erythroleukemia cell differentiation.
Topics: Animals; Bucladesine; Caffeine; Cell Differentiation; Cell Line; Cyclic AMP; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Synergism; Erythropoiesis; Heme; Hemoglobins; Leukemia, Erythroblastic, Acute; Mice; Theophylline | 1986 |